The US Food and Drug Administration (FDA) Advisory Committee recommends Moderna Booster for many adults

A pharmacist administers a third dose of the Moderna COVID-19 vaccine to a customer at a Michigan pharmacy last August.

Emily Elkonen / Getty Images

For the latest news and information about the coronavirus pandemic, visit the World Health Organization and Centers for Disease Control and Prevention websites.

An advisory panel to the U.S. Food and Drug Administration voted Thursday to recommend a booster dose Moderna COVID-19 Vaccine For many Americans, at least six months after the second dose.

The panel voted unanimously yes on a half-dose dose for people age 65 or older, people age 18 or older at risk of severe COVID-19, and people age 18 or older whose occupation puts them at risk of contracting COVID-19. COVID-19. that’s it The same groups that become eligible for a Pfizer booster Last month.

COVID-19 vaccines are highly effective in preventing hospitalization and death. Over the summer, as the delta variant spreads in the United States, the number of cases, hospitalizations, and deaths from COVID-19 soared. Those who were not vaccinated were counted Almost all hospitalizations and deaths – Over 97% as of July.

While the United States is already providing Booster dose of Pfizer vaccine For some people, only 2.5% of people living in low-income countries have received at least one dose of the vaccine.

A vote by an FDA panel is not binding, but the agency will likely accept the recommendation. Food and Drug Administration Pfizer booster syringe approved Less than a week after an advisory committee made its recommendation.

The U.S. Food and Drug Administration (FDA) has already granted emergency authorization to obtain a third dose of the Moderna vaccine for some immunocompromised adults.

The committee meets again Friday to discuss a booster dose for the Johnson & Johnson COVID-19 vaccine.

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button